Texas Medical Cannabis Support Gains Momentum
Recent polling data indicates substantial and growing support for Texas medical cannabis legalization and the state’s existing Texas Compassionate Use Program (TCUP). A new study by Fabrizio, Lee and Associates found public backing, suggesting that expanded medical cannabis access could be an issue for candidates in the upcoming election season.
The findings emerge as the Texas Legislature recently approved an expansion of the TCUP, which permits dispensaries to provide low-THC cannabis products to patients with specific qualifying conditions such as autism, multiple sclerosis, and cancer. This aligns with broader national discussions, including potential federal reclassification of cannabis.
Public Endorsement for Medical Cannabis Access
The Fabrizio, Lee and Associates survey, which polled 1,000 Texans, highlighted significant support across the political spectrum:
- 75% of respondents expressed support for legalized medical marijuana, a figure that included 63% of Republicans.
- Despite operating for a decade, only 11% of voters were initially aware of the TCUP. However, after learning about the program, 73% of respondents favored its provision of medical cannabis for qualifying conditions.
- A notable 44% of voters indicated they would be more inclined to support a legislator who voted to expand the TCUP, while only 13% stated they would be less likely.
These figures underscore public interest in accessible medical cannabis options within the state, building on earlier coverage by Hemp Gazette regarding consistent support for cannabis reform in Texas.
Voter Sentiment on THC Regulation and Economic Impact
The Fabrizio, Lee and Associates poll is not an isolated finding. The Texas Hemp Business Council (THBC) noted that at least two other polls corroborate this strong support for legal, medical cannabis. A Ragnar Research Partners poll, conducted in summer 2025 among Texas Republican primary voters, revealed nuanced perspectives on THC regulation:
- 47% of Republican primary voters opposed banning hemp, compared to 37% who supported a ban.
- 45% opposed banning THC, while 35% supported a ban.
- A significant 72% of Republican primary voters believe military veterans should have access to THC products as an alternative to opioids.
- Concerns about market disruption were also evident, with 53% believing a ban could create opportunities for drug cartels and 55% anticipating an increase in black market sales.
Separately, a Baselice Poll from March 2025 indicated even broader support for medical cannabis, with 68% of respondents advocating for THC to remain legal but regulated in Texas. This poll further detailed:
- 57% of Republican voters supported allowing THC to remain legal, with only 29% desiring a ban.
- Among Democratic voters, 80% preferred legal THC, versus 10% who wanted it banned.
- 72% of Independents favored legal THC, while 17% supported an outright ban.
The consistent findings across these surveys suggest a preference among Texans for regulated access over prohibition, a sentiment echoed by the THBC, which stated, “Texans support access to hemp-derived THC with smart, enforceable regulations. They want age restrictions, testing, and consumer safety — not black-market chaos and government overreach.”
Implications for Texas Policy and Industry
The cumulative data from these polls presents a case for legislators to consider further expanding the Texas medical cannabis framework. The public and bipartisan support for medical access and regulated THC products indicates that policies aligning with these preferences are likely to resonate positively with voters. As previously reported by Hemp Gazette, these poll results reinforce public interest for such reforms.
The ongoing discussions at the federal level regarding cannabis reclassification could also influence future state-level policy decisions, potentially creating a more harmonized regulatory environment. For industry operators and investors, the sustained public support signals a potentially expanding market for medical cannabis products in Texas, provided regulatory frameworks evolve to meet consumer demand and safety standards.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
